parkinsonism with dementia of Guadeloupe

disease
On this page

Summary

parkinsonism with dementia of Guadeloupe (MONDO:0019977) is a disease. A subtype of dementia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: Unknown (Worldwide)
  • Phenotypes (HPO): 27

Clinical features

Signs & symptoms

Clinical features (HPO)

27 HPO clinical features (Orphanet curated; top 27 by frequency):

HPO IDTermFrequency
HP:0001300ParkinsonismVery frequent (80-99%)
HP:0002063RigidityVery frequent (80-99%)
HP:0002067BradykinesiaVery frequent (80-99%)
HP:0000511Vertical supranuclear gaze palsyFrequent (30-79%)
HP:0000571Hypometric saccadesFrequent (30-79%)
HP:0000726DementiaFrequent (30-79%)
HP:0000727Frontal lobe dementiaFrequent (30-79%)
HP:0000738HallucinationsFrequent (30-79%)
HP:0001278Orthostatic hypotensionFrequent (30-79%)
HP:0001332DystoniaFrequent (30-79%)
HP:0001336MyoclonusFrequent (30-79%)
HP:0002119VentriculomegalyFrequent (30-79%)
HP:0002120Cerebral cortical atrophyFrequent (30-79%)
HP:0002172Postural instabilityFrequent (30-79%)
HP:0002186ApraxiaFrequent (30-79%)
HP:0002193Pseudobulbar behavioral symptomsFrequent (30-79%)
HP:0002345Action tremorFrequent (30-79%)
HP:0002360Sleep abnormalityFrequent (30-79%)
HP:0003458EMG: myopathic abnormalitiesFrequent (30-79%)
HP:0005341Autonomic bladder dysfunctionFrequent (30-79%)
HP:0007045Midline brain calcificationsFrequent (30-79%)
HP:0007240Progressive gait ataxiaFrequent (30-79%)
HP:0010549Weakness due to upper motor neuron dysfunctionFrequent (30-79%)
HP:0012332Abnormal autonomic nervous system physiologyFrequent (30-79%)
HP:0012753T2 hypointense basal gangliaFrequent (30-79%)
HP:0030902Palmomental reflexFrequent (30-79%)
HP:0100315Lewy bodiesExcluded (0%)

Identifiers

Disease identifiers

FieldValue
Canonical nameparkinsonism with dementia of Guadeloupe
Mondo IDMONDO:0019977
Orphanet97355
ICD-11773801248
SNOMED CT715737004
UMLSC4275027
MedGen899794
GARD0019372
Is cancer (heuristic)no

Disease family

This is a subtype of dementia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › psychiatric disordercognitive disorderdementiaparkinsonism with dementia of Guadeloupe

Related subtypes (8): vascular dementia, Alzheimer disease, Lewy body dementia, hereditary dementia, dementia pugilistica, AIDS dementia complex, progressive dementia with neuroserpin inclusion bodies, childhood-onset dementia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.